Division of Neurocognitive Sciences, Psychiatry and Behavioral Sciences Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran; Department of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
Life Sci. 2019 May 1;224:33-40. doi: 10.1016/j.lfs.2019.03.045. Epub 2019 Mar 20.
G protein-coupled receptors (GPCRs) are a large family of transmembrane proteins that are expressed in many organs and serve as important drug targets. A new subgroup, namely orphan GPCRs, comprising many of these receptors has been discovered. These receptors exhibit diverse physiological functions and have been considered in many neurological disorders including Alzheimer's disease, Parkinson's disease, and multiple sclerosis (MS). GPR17, GPR30, GPR37, GPR40, GPR50, GPR54, GPR56, GPR65, GPR68, GPR75, GPR84, GPR97, GPR109, GPR124, and GPR126 are orphan GPCRs that have been reported with considerable effects in the prevention and/or treatment of MS in preclinical studies. In the present article, we reviewed the most recent findings regarding the role of orphan GPCRs in the treatment of MS.
G 蛋白偶联受体(GPCRs)是一大类跨膜蛋白,在许多器官中表达,是重要的药物靶点。新发现了一个亚群,即孤儿 GPCRs,其中包含许多此类受体。这些受体具有多种生理功能,在许多神经疾病中都有涉及,包括阿尔茨海默病、帕金森病和多发性硬化症(MS)。GPR17、GPR30、GPR37、GPR40、GPR50、GPR54、GPR56、GPR65、GPR68、GPR75、GPR84、GPR97、GPR109、GPR124 和 GPR126 是孤儿 GPCRs,在临床前研究中对预防和/或治疗 MS 具有相当大的作用。本文综述了最近关于孤儿 GPCRs 在治疗 MS 中的作用的研究结果。